In the News

Long-term variation in HbA1c, SBP levels associated with CVD risk in type 2 diabetes

Diabetes patients who developed cardiovascular disease were found to be older, to have had diabetes longer, and to have significantly higher and lower levels for total cholesterol and HDL cholesterol, respectively, as well as having high coefficients of variation for HbA1c and systolic blood pressure.

FDA warns about ketoacidosis and urinary tract infections with SGLT2 inhibitors

The warnings are based on a review finding 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes and 19 cases of life-threatening urosepsis and pyelonephritis.

Collaboration between generalists, subspecialists can improve glycemic control

A “virtual clinic” model involving consultations between diabetes subspecialists and primary care physicians was associated with glycemic improvements in treated patients and controls from the same practices, a British study found.

MKSAP quiz: Angina in a patient with type 2 diabetes

This month's quiz asks readers to evaluate a 59-year-old woman with type 2 diabetes who has continued to have chest pain with exertion despite the addition of multiple antianginal agents.

Breastfeeding associated with lower risk of diabetes incidence after gestational diabetes

Women who breastfed exclusively had a hazard ratio for diabetes of 0.46 compared to women who used formula exclusively.

No clear-cut choice among once-weekly GLP-1 receptor agonists

All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels, according to the systematic review and network meta-analysis.

Insulin needles failing to deploy

Several lots of the OmniPod Insulin Management System were affected by a recent field safety notification about needle mechanisms failing to deploy or demonstrating a delay in deployment.

Spotlight on gender differences

The differences in outcomes between men and women with diabetes were the focus of a scientific statement from the American Heart Association and a study from Diabetologia, both published this month.